Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?

David H. Johnson; Carlos L. Arteaga

doi:10.1200/JCO.2003.04.001

Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2227-2229
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	21
Issue number	12
DOIs	https://doi.org/10.1200/JCO.2003.04.001
State	Published - Jun 15 2003

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2003.04.001

Cite this

@article{9829fcc735424270bb41493b5e717a21,

title = "Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?",

author = "Johnson, {David H.} and Arteaga, {Carlos L.}",

year = "2003",

month = jun,

day = "15",

doi = "10.1200/JCO.2003.04.001",

language = "English (US)",

volume = "21",

pages = "2227--2229",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "12",

}

TY - JOUR

T1 - Gefitinib in recurrent non-small-cell lung cancer

T2 - An IDEAL trial?

AU - Johnson, David H.

AU - Arteaga, Carlos L.

PY - 2003/6/15

Y1 - 2003/6/15

UR - http://www.scopus.com/inward/record.url?scp=0037811751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037811751&partnerID=8YFLogxK

U2 - 10.1200/JCO.2003.04.001

DO - 10.1200/JCO.2003.04.001

M3 - Editorial

C2 - 12748243

AN - SCOPUS:0037811751

SN - 0732-183X

VL - 21

SP - 2227

EP - 2229

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 12

ER -

Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this